Cenobamate

Category: Anticonvulsant



Cenobamate Overview

Cenobamate, sold under the brand name Xcopri, is for the treatment of partial-onset seizures in adults.[2][3] It was approved for medical use in the United States in November 2019[2][3][4] and placed in Schedule V in March 2020.[5] Contents 1 Pharmacology 1.1 Pharmacodynamics 2 History 3 References 4 Further reading 5 External links Pharmacology Pharmacodynamics Cenobamate is a voltage-...

Read more Cenobamate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cenobamate

Recent Cenobamate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cenobamate
  • Tablet: 100mg, 12.5mg, 150mg, 200mg, 25mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cenobamate: (5 results)

Sorted by National Drug Code
  • 71699-102 Xcopri Maintenance PackXcopri Oral Kit by Sk Life Science, Inc.
  • 71699-103 Xcopri Maintenance PackXcopri Oral Kit by Sk Life Science, Inc.
  • 71699-201 Xcopri Titration PackXcopri Oral Kit by Sk Life Science, Inc.
  • 71699-202 Xcopri Titration PackXcopri Oral Kit by Sk Life Science, Inc.
  • 71699-203 Xcopri Titration PackXcopri Oral Kit by Sk Life Science, Inc.

Other drugs which contain Cenobamate or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 6 July 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA